Show
Sort by
-
- Journal Article
- A1
- open access
Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al
-
- Journal Article
- A1
- open access
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
-
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial
-
4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial
-
Whole pelvis radiotherapy for pathological node-positive prostate cancer
-
Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer
-
The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies
-
- Journal Article
- A1
- open access
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial
-
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy
-
Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors